Virtual app to support breast and colorectal cancer survivors
Official title: Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors After Completing Primary Treatment
Run by Nova Scotia Health Authority · NCT07312786 · Data updated 2026-11-12
This study will test whether a mobile app helps breast and colorectal cancer survivors after primary treatment manage follow-up care and find community and health-system resources.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Saint John, New Brunswick and 1 other locations) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07312786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) diagnosed with stage I–III breast or colorectal cancer who completed primary treatment (surgery and/or adjuvant systemic or radiation therapy) between 6 months and 5 years ago and can provide informed consent are ideal candidates.
✕Probably not a fit
Patients with metastatic disease, those still within 6 months of completing primary treatment, or people who cannot access or use a smartphone/internet are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Developed with SeamlessMD, the intervention is a mobile health application that serves as an information hub delivering timely, evidence-based guidance and links to resources for people after primary cancer treatment. The project is a feasibility implementation at two Atlantic Canadian cancer centres (Halifax QEII and Saint John Regional Hospital) where participants will have access to the app for six months. Researchers will collect user and provider feedback and completion of questionnaires to measure usability, acceptability, and practical issues with deployment. Findings will inform whether the app can be scaled or modified for broader survivorship care.
Why it matters
Potential benefit: If successful, the app could improve survivors' communication with care teams, help people follow recommended surveillance and self-management practices, and connect them to local supports.
How similar studies have gone: Other digital survivorship and care-navigation tools, including SeamlessMD deployments in perioperative and oncology settings, have shown promise for engagement and information delivery, but evidence of large effects on long-term clinical outcomes is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults older than 18 years, capable of providing informed consent * Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago
Where it's running
-
Centre for Clinical Research QEII Health Sciences Centre
Halifax, Nova Scotia, Canada Recruiting -
Saint John Regional Hospital
Saint John, New Brunswick, Canada Not yet recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-Load Blood Flow Restriction Training for Colorectal Cancer Survivors with Sarcopenia
This trial tests whether adding blood flow restriction to light resistance training improves muscle strength, function, and cancer-related fatigue in colorectal cancer survivors with probable sarcopenia.
-
CRAFT-G: a remote group program to help brain function after breast cancer
A remotely delivered group program called CRAFT-G tests whether group cognitive retraining and functional strategies can help breast cancer survivors with cognitive symptoms feel and function better.
-
Home-based tDCS for cognitive problems in breast cancer survivors with and without obesity
This will test whether home-based transcranial direct current stimulation (tDCS) can improve cancer-related memory, attention, or processing speed problems in breast cancer survivors and whether obesity changes the effect.
-
Combining motor imagery and watching action videos to improve upper‑limb function in female breast cancer survivors
This trial will test whether combining motor imagery with watching action videos can help improve arm strength, range of motion, pain, swelling, or fear of movement in women who have completed breast cancer treatment.
-
Moving on After Breast Cancer: support for breast cancer survivors with depression in Pakistan
This trial will test a three-stage adaptive program to see if it helps breast cancer survivors in Pakistan who have major depression feel better and lowers care costs.
-
Prolonged nightly fasting to improve sleep and cognition in breast cancer survivors
This study is testing if a nightly fasting plan can help breast cancer survivors improve their sleep, thinking skills, and overall well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.